STAT on Nostr: The FDA expanded the approval for GSK’s vaccine to protect against RSV authorizing ...

The FDA expanded the approval for GSK’s vaccine to protect against RSV authorizing its use for at-risk adults as young as 50.

https://www.statnews.com/2024/06/07/gsk-rsv-vaccine-fda-expanded-approval-cdc-arexvy/?utm_medium=social&utm_source=mastodon&utm_campaign=mastodon_organic